Related Experiment Video
Updated: Jul 13, 2026
10:28
Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
Autoinhibition of c-Abl
Helma Pluk1, Karel Dorey, Giulio Superti-Furga
1Developmental Biology Programme, European Molecular Biology Laboratory, 69117 Heidelberg, Germany.
Cell
|February 8, 2002
Summary
Researchers discovered that the c-Abl tyrosine kinase
Area of Science:
- Molecular Biology
- Biochemistry
- Oncology
Background:
- The precise molecular mechanisms governing c-Abl tyrosine kinase activity have been a long-standing research question.
- Dysregulation of c-Abl is implicated in various cancers, particularly chronic myeloid leukemia through the BCR-Abl fusion protein.
Purpose of the Study:
- To elucidate the intrinsic regulatory mechanisms of the c-Abl tyrosine kinase.
- To identify the specific protein domains responsible for c-Abl autoregulation.
- To understand the role of c-Abl regulation in oncogenesis and BCR-Abl deregulation.
Main Methods:
- In vitro catalytic activity assays using purified c-Abl protein.
- Biochemical analyses to investigate protein-protein interactions.
- Assessment of the functional consequences of N-terminal modifications on c-Abl activity.
Main Results:
- Demonstrated that c-Abl possesses intrinsic inhibitory capabilities, regulating its own catalytic activity.
- Identified the N-terminal 80 residues as a crucial 'cap' domain mediating autoregulation.
- Showed that loss of this N-terminal cap domain results in oncogenic transformation and contributes to BCR-Abl deregulation.
Conclusions:
- Autoregulation is an inherent property of c-Abl tyrosine kinase, mediated by its N-terminal domain.
- The N-terminal cap is essential for maintaining c-Abl inhibition.
- Disruption of this regulatory cap is a key event in c-Abl oncogenic activation and BCR-Abl related leukemogenesis.
Related Concept Videos
01:52Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:19Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
00:50Anaphase Promoting Complex
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...